Reduction in levels of adiponectin which is produced by adipocytes has been reported in several studies in patients with insulin resistance, metabolic syndrome, obesity and NAFLD 2,14–17. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.